241 related articles for article (PubMed ID: 23386604)
41. Shared determinants of receptor binding for subtype selective, and dual endothelin-angiotensin antagonists on the AT1 angiotensin II receptor.
Dascal D; Nirula V; Lawus K; Yoo SE; Walsh TF; Sandberg K
FEBS Lett; 1998 Feb; 423(1):15-8. PubMed ID: 9506833
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin II cyclic analogs as tools to investigate AT
St-Pierre D; Cabana J; Holleran BJ; Besserer-Offroy É; Escher E; Guillemette G; Lavigne P; Leduc R
Biochem Pharmacol; 2018 Aug; 154():104-117. PubMed ID: 29684376
[TBL] [Abstract][Full Text] [Related]
43. Short peptide constructs mimic agonist sites of AT(1)R and BK receptors.
Lopes DD; Vieira RF; Malavolta L; Poletti EF; Shimuta SI; Paiva AC; Schreier S; Oliveira L; Nakaie CR
Amino Acids; 2013 Mar; 44(3):835-46. PubMed ID: 23096780
[TBL] [Abstract][Full Text] [Related]
44. Role of transmembrane helix IV in G-protein specificity of the angiotensin II type 1 receptor.
Feng YH; Karnik SS
J Biol Chem; 1999 Dec; 274(50):35546-52. PubMed ID: 10585429
[TBL] [Abstract][Full Text] [Related]
45. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket.
Boucard AA; Roy M; Beaulieu ME; Lavigne P; Escher E; Guillemette G; Leduc R
J Biol Chem; 2003 Sep; 278(38):36628-36. PubMed ID: 12842881
[TBL] [Abstract][Full Text] [Related]
46. Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1).
Yamano Y; Ohyama K; Kikyo M; Sano T; Nakagomi Y; Inoue Y; Nakamura N; Morishima I; Guo DF; Hamakubo T
J Biol Chem; 1995 Jun; 270(23):14024-30. PubMed ID: 7775462
[TBL] [Abstract][Full Text] [Related]
47. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
Patny A; Desai PV; Avery MA
Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
[TBL] [Abstract][Full Text] [Related]
48. Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor.
Balakumar P; Jagadeesh G
J Mol Endocrinol; 2014 Oct; 53(2):R71-92. PubMed ID: 25013233
[TBL] [Abstract][Full Text] [Related]
49. Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan.
Ji H; Leung M; Zhang Y; Catt KJ; Sandberg K
J Biol Chem; 1994 Jun; 269(24):16533-6. PubMed ID: 8206967
[TBL] [Abstract][Full Text] [Related]
50. Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor.
Deflorian F; Jacobson KA
J Comput Aided Mol Des; 2011 Apr; 25(4):329-38. PubMed ID: 21461952
[TBL] [Abstract][Full Text] [Related]
51. Mutational analysis of the angiotensin type 2 receptor: contribution of conserved amino acids in the region of the sixth transmembrane domain.
Heerding JN; Yee DK; Krichavsky MZ; Fluharty SJ
Regul Pept; 1998 Jun; 74(2-3):113-9. PubMed ID: 9712171
[TBL] [Abstract][Full Text] [Related]
52. Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization.
Karip E; Turu G; Süpeki K; Szidonya L; Hunyady L
Neurochem Int; 2007 Oct; 51(5):261-7. PubMed ID: 17644220
[TBL] [Abstract][Full Text] [Related]
53. Identification and function of disulfide bridges in the extracellular domains of the angiotensin II type 2 receptor.
Heerding JN; Hines J; Fluharty SJ; Yee DK
Biochemistry; 2001 Jul; 40(28):8369-77. PubMed ID: 11444984
[TBL] [Abstract][Full Text] [Related]
54. Genetic code expansion and photocross-linking identify different β-arrestin binding modes to the angiotensin II type 1 receptor.
Gagnon L; Cao Y; Cho A; Sedki D; Huber T; Sakmar TP; Laporte SA
J Biol Chem; 2019 Nov; 294(46):17409-17420. PubMed ID: 31530642
[TBL] [Abstract][Full Text] [Related]
55. Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.
Forfar R; Lu ZL
J Biol Chem; 2011 Oct; 286(40):34617-26. PubMed ID: 21832286
[TBL] [Abstract][Full Text] [Related]
56. Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor.
Costa-Neto CM; Miyakawa AA; Oliveira L; Hjorth SA; Schwartz TW; Paiva AC
Br J Pharmacol; 2000 Jul; 130(6):1263-8. PubMed ID: 10903964
[TBL] [Abstract][Full Text] [Related]
57. Activation of ERK, JNK, Akt, and G-protein coupled signaling by hybrid angiotensin II AT1/bradykinin B2 receptors expressed in HEK-293 cells.
Yu J; Lubinsky D; Tsomaia N; Huang Z; Taylor L; Mierke D; Navarro J; Miraz O; Polgar P
J Cell Biochem; 2007 May; 101(1):192-204. PubMed ID: 17212359
[TBL] [Abstract][Full Text] [Related]
58. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction.
Noda K; Feng YH; Liu XP; Saad Y; Husain A; Karnik SS
Biochemistry; 1996 Dec; 35(51):16435-42. PubMed ID: 8987975
[TBL] [Abstract][Full Text] [Related]
59. Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking.
Sokkar P; Mohandass S; Ramachandran M
J Mol Model; 2011 Jul; 17(7):1565-77. PubMed ID: 20924625
[TBL] [Abstract][Full Text] [Related]
60. Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor.
Takezako T; Unal H; Karnik SS; Node K
Mol Pharmacol; 2015 Sep; 88(3):488-501. PubMed ID: 26121982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
